NPI: 1932427119 · MILWAUKEE, WI 53212 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/12/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/12/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 32,453 | $635K |
| 2019 | 29,902 | $643K |
| 2020 | 26,295 | $426K |
| 2021 | 25,530 | $486K |
| 2022 | 16,349 | $542K |
| 2023 | 8,731 | $364K |
| 2024 | 6,369 | $321K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 55,537 | 4,282 | $3.39M |
| A4657 | Syringe, with or without needle, each | 3,175 | 2,583 | $13K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 562 | 246 | $7K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 39,654 | 1,981 | $5K |
| J1756 | Injection, iron sucrose, 1 mg | 10,360 | 2,182 | $1K |
| J1270 | Injection, doxercalciferol, 1 mcg | 26,262 | 2,009 | $445.81 |
| G0008 | Administration of influenza virus vaccine | 113 | 101 | $406.00 |
| 83970 | 1,744 | 1,457 | $10.47 | |
| 82728 | 890 | 761 | $2.04 | |
| 83550 | 909 | 774 | $1.31 | |
| 83540 | 931 | 789 | $0.97 | |
| 85041 | 2,073 | 1,652 | $0.75 | |
| 85048 | 2,047 | 1,630 | $0.63 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 484 | 245 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 801 | 547 | $0.00 |
| 90674 | 87 | 77 | $0.00 |